RxDoctor Payments Data

Karen Lane, APRN

Psychiatric/Mental Health · Greeneville, TNNPI 1063544666

Payments from drug & device makers

$3,188in general payments, 2019–2025

Across 184 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$529
  • Teva Pharmaceuticals USA, Inc.$496
  • AbbVie$461
  • Neurocrine Biosciences, Inc.$315
  • Vanda Pharmaceuticals Inc.$270
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$236
  • plus $880 from 12 others

What the payments were for

  • Food & beverage$3,14199%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,188 in reported general payments places this provider in the 80th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$8,848
Medicare patients
22
Services billed
84

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole74$116,488
VraylarCariprazine Hcl73$112,013
Abilify MaintenaAripiprazole21$60,774
Invega SustennaPaliperidone Palmitate13$42,000
FanaptIloperidone24$25,744
TrintellixVortioxetine Hydrobromide34$17,140
Vilazodone Hcl48$6,014
Aripiprazole89$2,550
Bupropion XlBupropion Hcl88$2,253
Venlafaxine Hcl ErVenlafaxine Hcl64$1,885
Trazodone Hcl88$1,457
Lamotrigine99$1,314
Ziprasidone Hcl28$1,207
Duloxetine Hcl48$1,173
Mirtazapine75$1,063

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$529$177,26295 claims
AbbVieVraylar$461$112,01373 claims
Johnson & JohnsonInvega Sustenna$67$42,00013 claims
Vanda Pharmaceuticals Inc.Fanapt$270$25,74424 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$67$17,14034 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Greeneville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →